TetraLogic Pharmaceuticals

About:

TetraLogic Pharmaceuticals discovers and develops small molecule drugs for the treatment of debilitating diseases and conditions.

Website: http://www.tetralogicpharma.com

Top Investors: Pfizer Venture Investments, Nextech Invest, Hatteras Venture Partners, Amgen Ventures, Clarus Ventures

Description:

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company's Smac Mimetics neutralize critical blocks in the apoptosis pathway to selectively destroy cancer cells. Its Necrostatin drugs block critical steps in the process leading to necrosis, enabling cell survival in a wide range of diseases and injuries where necrosis is a critical component of pathology.